Artículos de revistas
Taurine Prevents Fat Deposition And Ameliorates Plasma Lipid Profile In Monosodium Glutamate-obese Rats
Registro en:
Amino Acids. , v. 41, n. 4, p. 901 - 908, 2011.
9394451
10.1007/s00726-010-0789-7
2-s2.0-83255177062
Autor
Nardelli T.R.
Ribeiro R.A.
Balbo S.L.
Vanzela E.C.
Carneiro E.M.
Boschero A.C.
Bonfleur M.L.
Institución
Resumen
The aim of the present study was to evaluate the preventive effects of taurine (TAU) supplementation upon monosodium glutamate (MSG)-induced obesity. Rats treated during the first 5 days of life with MSG or saline were distributed into the following groups: control (CTL), CTL-treated with TAU (CTAU), MSG and MSG-supplemented with TAU (MTAU). CTAU and MTAU received 2.5% of TAU in their drinking water from 21 to 90 days of life. At the end of treatment, MSG and MTAU rats were hyperinsulinemic, glucose intolerant and insulin resistant, as judged by the HOMA index. MSG and MTAU rat islets secreted more insulin at 16.7 mM glucose compared to CTL. MSG rats also showed higher triglycerides (TG) and non-esterified fatty acids (NEFA) plasma levels, Lee Index, retroperitoneal and periepidydimal fat pads, compared with CTL, whereas plasma lipid concentrations and fat depots were lower in MTAU, compared with MSG rats. In addition, MSG rats had a higher liver TG content compared with CTL. TAU decreased liver TG content in both supplemented groups, but fat content only in MTAU rats. TAU supplementation did not change glucose homeostasis, insulin secretion and action, but reduced plasma and liver lipid levels in MSG rats. © Springer-Verlag 2010. 41 4 901 908 Anuradha, C.V., Balakrishnan, S.D., Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat: An animal model of insulin resistance (1999) Can J Physiol Pharmacol, 77, pp. 749-754 Balbo, S.L., Mathias, P.C., Bonfleur, M.L., Alves, H.F., Siroti, F.J., Monteiro, O.G., Ribeiro, F.B., Souza, A.C., Vagotomy reduces obesity in MSG-treated rats (2000) Res Commun Mol Pathol Pharmacol, 108, pp. 291-296 Balbo, S.L., Grassiolli, S., Ribeiro, R.A., Bonfleur, M.L., Gravena, C., Brito Mdo, N., Andreazzi, A.E., Torrezan, R., Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat (2007) Endocrine, 31, pp. 142-148 Bernardis, L.L., Patterson, B.D., Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions (1968) J Endocrinol, 40, pp. 527-528 Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M., Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity (2000) Diabetes Care, 23, pp. 57-63 Boujendar, S., Reusens, B., Merezak, S., Ahn, M.T., Arany, E., Hill, D., Remacle, C., Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets (2002) Diabetologia, 45, pp. 856-866 Carneiro, E.M., Latorraca, M.Q., Araujo, E., Beltra, M., Oliveras, M.J., Navarro, M., Berna, G., Martin, F., Taurine supplementation modulates glucose homeostasis and islet function (2009) J Nutr Biochem, 20, pp. 503-511 Chen, W., Matuda, K., Nishimura, N., Yokogoshi, H., The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet (2004) Life Sci, 74, pp. 1889-1898 Cherif, H., Reusens, B., Dahri, S., Remacle, C., Hoet, J.J., Stimulatory effects of taurine on insulin secretion by fetal rat islets cultured in vitro (1996) J Endocrinol, 151, pp. 501-506 Cherif, H., Reusens, B., Ahn, M.T., Hoet, J.J., Remacle, C., Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet (1998) J Endocrinol, 159, pp. 341-348 Choi, M.J., Kim, J.H., Chang, K.J., The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet (2006) Adv Exp Med Biol, 583, pp. 235-242 Dashti, N., The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells (1992) J Biol Chem, 267, pp. 7160-7169 Dawson Jr., R., Acute and long lasting neurochemical effects of monosodium glutamate administration to mice (1983) Neuropharmacology, 22, pp. 1417-1419 Duivenvoorden, I., Teusink, B., Rensen, P.C., Romijn, J.A., Havekes, L.M., Voshol, P.J., Apolipoprotein C3 deficiency results in dietinduced obesity and aggravated insulin resistance in mice (2005) Diabetes, 54, pp. 664-671 Folch, J., Lees, M., Sloane Stanley, G.H., A simple method for the isolation and purification of total lipides from animal tissues (1957) J Biol Chem, 226, pp. 497-509 Huxtable, R.J., Physiological actions of taurine (1992) Physiol Rev, 72, pp. 101-163 Kahn, S.E., Prigeon, R.L., Schwartz, R.S., Fujimoto, W.Y., Knopp, R.H., Brunzell, J.D., Porte Jr., D., Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity (2001) J Nutr, 131, pp. 354S-360S Kaniuk, N.A., Kiraly, M., Bates, H., Vranic, M., Volchuk, A., Brumell, J.H., Ubiquitinated-protein aggregates form in pancreatic betacells during diabetes-induced oxidative stress and are regulated by autophagy (2007) Diabetes, 56, pp. 930-939 Kaplan, B., Karabay, G., Zagyapan, R.D., Ozer, C., Sayan, H., Duyar, I., Effects of taurine in glucose and taurine administration (2004) Amino Acids, 27, pp. 327-333 Kulakowski, E.C., Maturo, J., Hypoglycemic properties of taurine: Not mediated by enhanced insulin release (1984) Biochem Pharmacol, 33, pp. 2835-2838 Macho, L., Fickova, M., Jezova Zorad, S., Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats (2000) Physiol Res, 49 (1 SUPPL.), pp. S79-S85 Martins, A.C., Souza, K.L., Shio, M.T., Mathias, P.C., Lelkes, P.I., Garcia, R.M., Adrenal medullary function and expression of catecholamine- synthesizing enzymes in mice with hypothalamic obesity (2004) Life Sci, 74, pp. 3211-3222 Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man (1985) Diabetologia, 28, pp. 412-419 Maturo, J., Kulakowski, E.C., Taurine binding to the purified insulin receptor (1988) Biochem Pharmacol, 37, pp. 3755-3760 Mizushima, S., Nara, Y., Sawamura, M., Yamori, Y., Effects of oral taurine supplementation on lipids and sympathetic nerve tone (1996) Adv Exp Med Biol, 403, pp. 615-622 Murakami, S., Kondo, Y., Nagate, T., Effects of long-term treatment with taurine in mice fed a high-fat diet: Improvement in cholesterol metabolism and vascular lipid accumulation by taurine (2000) Adv Exp Med Biol, 483, pp. 177-186 Murakami, S., Kondo, Y., Toda, Y., Kitajima, H., Kameo, K., Sakono, M., Fukuda, N., Effect of taurine on cholesterol metabolism in hamsters: Up-regulation of low density lipoprotein (LDL) receptor by taurine (2002) Life Sci, 70, pp. 2355-2366 Nakaya, Y., Minami, A., Harada, N., Sakamoto, S., Niwa, Y., Ohnaka, M., Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes (2000) Am J Clin Nutr, 71, pp. 54-58 Nandhini, A.T., Thirunavukkarasu, V., Anuradha, C.V., Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats (2005) Diabetes Metab, 31, pp. 337-344 Nishimura, N., Umeda, C., Ona, H., Yokogoshi, H., The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats (2002) J Nutr Sci Vitaminol (Tokyo, 48, pp. 483-490 Olney, J.W., Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate (1969) Science, 164, pp. 719-721 Olney, J.W., Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study (1971) J Neuropathol Exp Neurol, 30, pp. 75-90 Olofsson, S.O., Boren, J., Apolipoprotein B: A clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis (2005) J Intern Med, 258, pp. 395-410 Ribeiro, R.A., Bonfleur, M.L., Amaral, A.G., Vanzela, E.C., Rocco, S.A., Boschero, A.C., Carneiro, E.M., Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets (2009) Diabetes Metab Res Rev, 25, pp. 370-379 Ribeiro, R.A., Vanzela, E.C., Oliveira, C.A., Bonfleur, M.L., Boschero, A.C., Carneiro, E.M., Taurine supplementation: Involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2+ handling in mouse pancreatic islets (2010) Br J Nutr, 104 (8), pp. 1148-1155 Tas, S., Sarandol, E., Ayvalik, S.Z., Serdar, Z., Dirican, M., Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: Effects on the oxidative and antioxidative systems (2007) Arch Med Res, 38, pp. 276-283 Tsuboyama-Kasaoka, N., Shozawa, C., Sano, K., Kamei, Y., Kasaoka, S., Hosokawa, Y., Ezaki, O., Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity (2006) Endocrinology, 147, pp. 3276-3284 Xiao, C., Giacca, A., Lewis, G.F., Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men (2008) Diabetologia, 51, pp. 139-146 Yanagita, T., Han, S.Y., Hu, Y., Nagao, K., Kitajima, H., Murakami, S., Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells (2008) Lipids Health Dis, 7, p. 38 Zhang, M., Bi, L.F., Fang, J.H., Su, X.L., Da, G.L., Kuwamori, T., Kagamimori, S., Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects (2004) Amino Acids, 26, pp. 267-271